PNPLA3 and hepatocellular carcinoma: In secondary analysis, we assessed whether presence of the genetic risk variant PNPLA3 (I148M) rs738409 could further improve metabolic HCC prediction by combining this variant with differentially methylated CpGs and clinical and demographic variables.